MedTrace Logo

Photodynamic Therapy of Actinic Keratoses With Alacare®

NCT01571336 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 388

Last updated 2016-09-27

No results posted yet for this study

Summary

This study aims to collect data on the frequency of SCCs in the Alacare®-treated area during an interval of two years after Alacare®-PDT.

Conditions

  • Actinic Keratosis

Sponsors & Collaborators

  • photonamic GmbH & Co. KG

    lead INDUSTRY

Principal Investigators

  • Peter Radny, MD · Dermatological group practice, Charlottenstraße 12, D-88045 Friedrichshafen, Germany

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2016-05-31
Completion
2016-09-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01571336 on ClinicalTrials.gov